Followers | 507 |
Posts | 10138 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Thursday, October 30, 2014 12:44:21 PM
Topdown market analysis:
Market is _BULLISH_
Today is _UP_
Bullish Sector _BIOTECHNOLOGY_
bullish stock in this sector
$AGIO recent news/filings
## source: finance.yahoo.com
Wed, 29 Oct 2014 17:41:34 GMT ~ Nasdaq stocks posting largest percentage increases
read full: http://sg.finance.yahoo.com/news/nasdaq-stocks-posting-largest-percentage-220237991--finance.html
*********************************************************
Wed, 29 Oct 2014 10:00:00 GMT ~ 'Mad Money' Lightning Round: I'm Sticking With Isis Pharmaceuticals
read full: http://www.thestreet.com/story/12861472/1/mad-money-lightning-round-im-sticking-with-isis-pharmaceuticals.html?puc=yahoo&cm_ven=YAHOO
*********************************************************
Tue, 28 Oct 2014 23:24:10 GMT ~ Lightning Round: GNC, Goldman and more
read full: http://www.cnbc.com/id/102128707?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=102128707
*********************************************************
Tue, 28 Oct 2014 18:12:59 GMT ~ Two biotech leaders to watch
read full: http://www.marketwatch.com/News/Story/Story.aspx?guid=D7CCEB70-396E-49E4-BD03-2CB82C69AFAC&siteid=yhoof2
*********************************************************
Mon, 27 Oct 2014 13:11:41 GMT ~ Agios Pharmaceuticals to Webcast Conference Call of Third Quarter 2014 Financial Results on November 7, 2014
[at noodls] - CAMBRIDGE, Mass., Oct. 27, 2014 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq:AGIO), a leader in the fields of cancer metabolism and rare genetic disorders of metabolism, today announced that ...
read full: http://www.noodls.com/view/A2EF8BBB5ACD70924BD84BBCAE0F2381B1BCF76C
*********************************************************
$AGIO charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$AGIO company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/AGIO/company-info
Ticker: $AGIO
OTC Market Place: Not Available
CIK code: not found
Company name: Agios Pharmaceuticals, Inc.
Incorporated In:
Business Description:
http://www.agios.com/
Agios Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics in the field of cancer metabolism and inborn errors of metabolism (IEMs) in the United States. Its product candidates include AG-221, an oral inhibitor of the mutated isocitrate dehydrogenase (IDH) 2 protein for the treatment of patients with cancers that harbor IDH2 mutations, as well as for the Type II D-2 hydroxyglutaric aciduria treatment; and AG-120, an oral inhibitor of the mutated IDH1 protein for the treatment of patients with cancers that harbor IDH1 mutations. The company is also developing AG-348, an oral small molecule activator of PKR enzyme for the treatment of patients with pyruvate kinase deficiency. It has a collaboration agreement with Celgene Corporation to discover, develop, and commercialize disease-altering therapies in oncology. Agios Pharmaceuticals, Inc. was founded in 2007 and is based in Cambridge, Massachusetts.
$AGIO share structure
## source: otcmarkets.com
Market Value: Not Available
Shares Outstanding: Not Available
Float: Not Available
Authorized Shares: Not Available
Par Value: Not Available
$AGIO extra dd links
Company name: Agios Pharmaceuticals, Inc.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=AGIO+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=AGIO+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=AGIO+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/AGIO/news - http://finance.yahoo.com/q/h?s=AGIO+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/AGIO/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/AGIO/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=AGIO+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/AGIO
DTCC (dtcc.com): http://search2.dtcc.com/?q=Agios+Pharmaceuticals%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Agios+Pharmaceuticals%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Agios+Pharmaceuticals%2C+Inc.&x=0&y=0
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/AGIO
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/sec-filings
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/AGIO/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/AGIO/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=AGIO&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=AGIO
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/AGIO/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=AGIO+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=AGIO+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=AGIO
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=AGIO
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=AGIO+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/AGIO/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=AGIO+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/AGIO.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=AGIO
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/AGIO/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/AGIO
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/AGIO
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/AGIO:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=AGIO
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=AGIO
$AGIO DD Notes ~ http://www.ddnotesmaker.com/AGIO
Recent AGIO News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 11:47:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:20:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:18:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:15:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:10:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:06:38 PM
- Agios to Present at the Leerink Partners Global Biopharma Conference on March 12, 2024 • GlobeNewswire Inc. • 03/05/2024 12:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/01/2024 09:27:51 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/01/2024 09:26:29 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/01/2024 09:25:26 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/01/2024 09:22:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 09:05:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 09:04:46 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/27/2024 02:21:33 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 10:43:34 PM
- Agios to Present at the TD Cowen 44th Annual Health Care Conference on March 4, 2024 • GlobeNewswire Inc. • 02/22/2024 12:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/15/2024 03:33:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 12:03:50 PM
- Agios Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights • GlobeNewswire Inc. • 02/15/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 10:53:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 10:51:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 10:50:21 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 07:21:13 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 07:06:57 PM
- Agios to Webcast Conference Call of Fourth Quarter and Year End 2023 Financial Results on February 15, 2024 • GlobeNewswire Inc. • 02/02/2024 12:00:00 PM
Endexx Corporation (EDXC) Leverages Global Market Trends and Legislative Reforms to Spearhead Growth in the Cannabis and Plant-Based Wellness Sectors • EDXC • Mar 27, 2024 3:01 PM
Applied UV, Inc. Announces Pricing of $2.76 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules • AUVI • Mar 27, 2024 2:51 PM
POET and MultiLane Collaborate to Develop High-Speed Pluggable Transceivers for AI Networks • POET • Mar 27, 2024 10:52 AM
Maybacks Global Entertainment Opens 23 More Stations in Important Major Cities • AHRO • Mar 27, 2024 9:00 AM
NxGen Brands Inc. Forecast to Deliver 140% Growth in Q1 2024 • NXGB • Mar 27, 2024 7:30 AM
Kona Gold Beverages, Inc. Strategic Advancements: Covert LLC Introduces Federally Legal D9 Gummies and Revamps Innovative eCommerce Platform, Propelling Toward $12 Million Annual Revenue Goal • KGKG • Mar 26, 2024 8:30 AM